Connect your AI

Adaptive Biotechnologies ADPT Price / sales

Price / sales at other companies

Guardant HealthGH

11.2×+4.4×

Natera, Inc.NTRA

11.3×+0.9×

RevvityRVTY

3.4×-1.2×

VeracyteVCYT

4.7×-0.3×

DanaherDHR

5.4×-0.7×

Charles River LaboratoriesCRL

2.1×+0.2×

Other financials

Income statement

Revenue$70.9M+35.1%

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

Operating cash flow-$9.5M+66.5%

CapEx$796.0K-36.8%

Free cash flow-$10.3M+65.3%

Valuation

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

Profitability

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Calculated from Adaptive Biotechnologies’s reported figures.

market cap/total revenue=7.2×

Based on the most recent quarter.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Adaptive Biotechnologies's price / sales?: Adaptive Biotechnologies (ADPT) reported price / sales of 7.2× in Q1 2026.
How has Adaptive Biotechnologies's price / sales changed year-over-year?: Adaptive Biotechnologies's price / sales increased by 24.2% year-over-year, from 5.8× to 7.2×.
What is the long-term trend for Adaptive Biotechnologies's price / sales?: Over 5 years (2020 to 2025), Adaptive Biotechnologies's price / sales has grown at a -36.2% compound annual growth rate (CAGR), from 84.8× to 9×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.